Yanagitani N - Search Results

1

Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.

Nishio M, Horiike A, Nokihara H, Horinouchi H, Nakamichi S, Wakui H, Ohyanagi F, Kudo K, Yanagitani N, Takahashi S, Kuboki Y, Yamamoto N, Yamada Y, Abe M, Tahata T, Tamura T. Nishio M, et al. Among authors: yanagitani n. Invest New Drugs. 2015 Jun;33(3):632-40. doi: 10.1007/s10637-015-0227-5. Epub 2015 Mar 18. Invest New Drugs. 2015. PMID: 25777467 Clinical Trial.

2

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.

Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, Saito R, Yokota J. Yanagitani N, et al. Carcinogenesis. 2002 Jul;23(7):1177-83. doi: 10.1093/carcin/23.7.1177. Carcinogenesis. 2002. PMID: 12117776

3

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.

Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J. Sunaga N, et al. Among authors: yanagitani n. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):730-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163326

4

Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markers.

Yanagitani N, Kohno T, Kim JG, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J. Yanagitani N, et al. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):366-71. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692112 Clinical Trial.

5

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Shimizu Y, Iijima H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M. Kaira K, et al. Among authors: yanagitani n. Anticancer Drugs. 2007 Apr;18(4):471-6. doi: 10.1097/CAD.0b013e32801265eb. Anticancer Drugs. 2007. PMID: 17351400 Clinical Trial.

6

Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Aoki H, Kawata T, Utsugi M, Shimizu Y, Shimizu K, Hisada T, Ishizuka T, Mori M. Kaira K, et al. Among authors: yanagitani n. Anticancer Drugs. 2008 Mar;19(3):289-94. doi: 10.1097/cad.0b013e3282f3fd41. Anticancer Drugs. 2008. PMID: 18510175 Clinical Trial.

7

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.

Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M. Kudo K, et al. Among authors: yanagitani n. Lung Cancer. 2011 Dec;74(3):401-4. doi: 10.1016/j.lungcan.2011.03.019. Epub 2011 Apr 29. Lung Cancer. 2011. PMID: 21529988

8

[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].

Yanagitani N, Horiike A, Kudo K, Ohyanagi F, Nishio M, Horai T. Yanagitani N, et al. Nihon Kokyuki Gakkai Zasshi. 2011 Apr;49(4):282-6. Nihon Kokyuki Gakkai Zasshi. 2011. PMID: 21591457 Japanese.

9

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor.

Sakai K, Horiike A, Irwin DL, Kudo K, Fujita Y, Tanimoto A, Sakatani T, Saito R, Kaburaki K, Yanagitani N, Ohyanagi F, Nishio M, Nishio K. Sakai K, et al. Among authors: yanagitani n. Cancer Sci. 2013 Sep;104(9):1198-204. doi: 10.1111/cas.12211. Epub 2013 Jul 1. Cancer Sci. 2013. PMID: 23721103 Free PMC article.

10

Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients: phase II study.

Kawano Y, Ohyanagi F, Yanagitani N, Kudo K, Horiike A, Tanimoto A, Nishizawa H, Ichikawa A, Sakatani T, Nakatomi K, Hagiwara S, Ninomiya H, Motoi N, Ishikawa Y, Horai T, Nishio M. Kawano Y, et al. Among authors: yanagitani n. Anticancer Res. 2013 Aug;33(8):3327-33. Anticancer Res. 2013. PMID: 23898099 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters